Cited by 65

Sphingosine-1-Phosphate (S1P) Impacts Presynaptic Functions by Regulating Synapsin I Localization in the Presynaptic Compartment

Riganti, Loredana, Antonucci, Flavia, Gabrielli, Martina, Prada, Ilaria, Giussani, Paola, Viani, Paola, Valtorta, Flavia, Menna, Elisabetta +2 more·2016·The Journal of Neuroscience

Abstract

Growing evidence indicates that sphingosine-1-P (S1P) upregulates glutamate secretion in hippocampal neurons. However, the molecular mechanisms through which S1P enhances excitatory activity remain largely undefined. The aim of this study was to identify presynaptic targets of S1P action controlling exocytosis. Confocal analysis of rat hippocampal neurons showed that S1P applied at nanomolar concentration alters the distribution of Synapsin I (SynI), a presynaptic phosphoprotein that controls the availability of synaptic vesicles for exocytosis. S1P induced SynI relocation to extrasynaptic regions of mature neurons, as well as SynI dispersion from synaptic vesicle clusters present at axonal growth cones of developing neurons. S1P-induced SynI relocation occurred in a Ca 2+-independent but ERK-dependent manner, likely through the activation of S1P 3 receptors, as it was prevented by the S1P 3 receptor selective antagonist CAY1044 and in neurons in which S1P 3 receptor was silenced. Our recent evidence indicates that microvesicles (MVs) released by microglia enhance the metabolism of endogenous sphingolipids in neurons and stimulate excitatory transmission. We therefore investigated whether MVs affect SynI distribution and whether endogenous S1P could be involved in the process. Analysis of SynI immunoreactivity showed that exposure to microglial MVs induces SynI mobilization at presynaptic sites and growth cones, whereas the use of inhibitors of sphingolipid cascade identified S1P as the sphingolipid mediating SynI redistribution. Our data represent the first demonstration that S1P induces SynI mobilization from synapses, thereby indicating the phosphoprotein as a novel target through which S1P controls exocytosis. SIGNIFICANCE STATEMENT Growing evidence indicates that the bioactive lipid sphingosine and its metabolite sphingosine-1-P (S1P) stimulate excitatory transmission. While it has been recently clarified that sphingosine influences directly the exocytotic machinery by activating the synaptic vesicle protein VAMP2 to form SNARE fusion complexes, the molecular mechanism by which S1P promotes neurotransmission remained largely undefined. In this study, we identify Synapsin I, a presynaptic phosphoprotein involved in the control of availability of synaptic vesicles for exocytosis, as the key target of S1P action. In addition, we provide evidence that S1P can be produced at mature axon terminals as well as at immature growth cones in response to microglia-derived signals, which may be important to stabilize nascent synapses and to restore or potentiate transmission.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3588-15.2016

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 44

  1. Antonucci F, Turola E, Riganti L, Caleo M, Gabrielli M, Perrotta C, Novellino L, Clementi E, Giussani P, Viani P, Matteoli M, Verderio C (2012) Mi- crovesicles released from microglia stimulate synaptic activity via en- hanced sphingolipid metabolism. EMBO J 31:1231-1240. CrossRef Medline · DOI · Paper page
  2. Banker G, Groslin K (1998) Culturing nerve cell. Cambridge, MA: Massa- chusetts Institute of Technology.
  3. Bonanomi D, Menegon A, Miccio A, Ferrari G, Corradi A, Kao HT, Benfenati F, Valtorta F (2005) Phosphorylation of synapsin I by cAMP-dependent protein kinase controls synaptic vesicle dynamics in developing neurons. J Neurosci 25:7299 -7308. CrossRef Medline · DOI
  4. Cesca F, Baldelli P, Valtorta F, Benfenati F (2010) The synapsins: key actors of synapse function and plasticity. Prog Neurobiol 91:313-348. CrossRef Medline · DOI · Paper page
  5. Chan JP, Sieburth D (2012) Localized sphingolipid signaling at presynaptic terminals is regulated by calcium influx and promotes recruitment of priming factors. J Neurosci 32:17909 -17920. CrossRef Medline · DOI
  6. Chan JP, Hu Z, Sieburth D (2012) Recruitment of sphingosine kinase to presynaptic terminals by a conserved muscarinic signaling pathway pro- motes neurotransmitter release. Genes Dev 26:1070 -1085. CrossRef Medline · DOI
  7. Chang S, De Camilli P (2001) Glutamate regulates actin-based motility in axonal filopodia. Nat Neurosci 4:787-793. CrossRef Medline · DOI
  8. Choi JW, Chun J (2013) Lysophospholipids and their receptors in the cen- tral nervous system. Biochim Biophys Acta 1831:20 -32. CrossRef Medline · DOI
  9. Choi JW, Gardell SE, Herr DR, Rivera R, Lee CW, Noguchi K, Teo ST, Yung YC, Lu M, Kennedy G, Chun J (2011) FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc Natl Acad Sci U S A 108:751-756. CrossRef Medline · DOI
  10. Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pel- letier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 362:402-415. CrossRef Medline · DOI
  11. Darios F, Wasser C, Shakirzyanova A, Giniatullin A, Goodman K, Munoz- Bravo JL, Raingo J, Jorgacevski J, Kreft M, Zorec R, Rosa JM, Gandia L, Gutie ´rrez LM, Binz T, Giniatullin R, Kavalali ET, Davletov B (2009) Sphingosine facilitates SNARE complex assembly and activates synaptic vesicle exocytosis. Neuron 62:683-694. CrossRef Medline · DOI
  12. Davletov B, Montecucco C (2010) Lipid function at synapses. Curr Opin Neurobiol 20:543-549. CrossRef Medline · DOI
  13. Di Menna L, Molinaro G, Di Nuzzo L, Riozzi B, Zappulla C, Pozzilli C, Turrini R, Caraci F, Copani A, Battaglia G, Nicoletti F, Bruno V (2013) Fingolimod protects cultured cortical neurons against excitotoxic death. Pharmacol Res 67:1-9. CrossRef Medline · DOI
  14. Doi Y, Takeuchi H, Horiuchi H, Hanyu T, Kawanokuchi J, Jin S, Parajuli B, Sonobe Y, Mizuno T, Suzumura A (2013) Fingolimod phosphate atten- uates oligomeric amyloid ␤-induced neurotoxicity via increased brain- derived neurotrophic factor expression in neurons. PLoS One 8:e61988. CrossRef Medline · DOI
  15. Fornasiero EF, Bonanomi D, Benfenati F, Valtorta F (2010) The role of synapsins in neuronal development. Cell Mol Life Sci 67:1383-1396. CrossRef Medline · DOI
  16. Foster CA, Howard LM, Schweitzer A, Persohn E, Hiestand PC, Balatoni B, Reuschel R, Beerli C, Schwartz M, Billich A (2007) Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomy- elitis: consequences for mode of action in multiple sclerosis. J Pharmacol Exp Ther 323:469 -475. CrossRef Medline · DOI
  17. Gabrielli M, Battista N, Riganti L, Prada I, Antonucci F, Cantone L, Matteoli M, Maccarrone M, Verderio C (2015) Active endocannabinoids are se- creted on extracellular membrane vesicles. EMBO Rep 16:213-220. CrossRef Medline · DOI · Paper page
  18. García-Martínez V, Villanueva J, Torregrosa-Hetland CJ, Bittman R, Higdon A, Darley-Usmar VM, Davletov B, Gutie ´rrez LM (2013) Lipid metabo- lites enhance secretion acting on SNARE microdomains and altering the extent and kinetics of single release events in bovine adrenal chromaffin cells. PLoS One 8:e75845. CrossRef Medline · DOI
  19. Gelsomino G, Menna E, Antonucci F, Rodighiero S, Riganti L, Mulle C, Benfenati F, Valtorta F, Verderio C, Matteoli M (2013) Kainate induces mobilization of synaptic vesicles at the growth cone through the activa- tion of protein kinase A. Cereb Cortex 23:531-541. CrossRef Medline · DOI
  20. Giussani P, Ferraretto A, Gravaghi C, Bassi R, Tettamanti G, Riboni L, Viani P (2007) Sphingosine-1-phosphate and calcium signaling in cerebellar astrocytes and differentiated granule cells. Neurochem Res 32:27-37. CrossRef Medline · DOI
  21. Hait NC, Wise LE, Allegood JC, O'Brien M, Avni D, Reeves TM, Knapp PE, Lu J, Luo C, Miles MF, Milstien S, Lichtman AH, Spiegel S (2014) Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory. Nat Neurosci 17:971-980. CrossRef Medline · DOI · Paper page
  22. Jovanovic JN, Benfenati F, Siow YL, Sihra TS, Sanghera JS, Pelech SL, Green- gard P, Czernik AJ (1996) Neurotrophins stimulate phosphorylation of synapsin I by MAP kinase and regulate synapsin I-actin interactions. Proc Natl Acad Sci U S A 93:3679 -3683. CrossRef Medline · DOI
  23. Kajimoto T, Okada T, Yu H, Goparaju SK, Jahangeer S, Nakamura S (2007) Involvement of sphingosine-1-phosphate in glutamate secretion in hip- pocampal neurons. Mol Cell Biol 27:3429 -3440. CrossRef Medline · DOI
  24. Kanno T, Nishizaki T (2011) Endogenous sphingosine 1-phosphate regu- lates spontaneous glutamate release from mossy fiber terminals via S1P(3) receptors. Life Sci 89:137-140. CrossRef Medline · DOI
  25. Kanno T, Nishizaki T, Proia RL, Kajimoto T, Jahangeer S, Okada T, Naka- mura S (2010) Regulation of synaptic strength by sphingosine 1-phosphate in the hippocampus. Neuroscience 171:973-980. CrossRef Medline · DOI
  26. Kappos L, Radue EW, O'Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclero- sis. N Engl J Med 362:387-401. CrossRef Medline · DOI
  27. Koide Y, Hasegawa T, Takahashi A, Endo A, Mochizuki N, Nakagawa M, Nishida A (2002) Development of novel EDG3 antagonists using a 3D database search and their structure-activity relationships. J Med Chem 45:4629 -4638. CrossRef Medline · DOI
  28. Kunkel GT, Maceyka M, Milstien S, Spiegel S (2013) Targeting the sphingosine-1-phosphate axis in cancer, inflammation and beyond. Nat Rev Drug Discov 12:688 -702. CrossRef Medline · DOI
  29. Menegon A, Bonanomi D, Albertinazzi C, Lotti F, Ferrari G, Kao HT, Benfe- nati F, Baldelli P, Valtorta F (2006) Protein kinase A-mediated synapsin I phosphorylation is a central modulator of Ca 2ϩ -dependent synaptic activity. J Neurosci 26:11670 -11681. CrossRef Medline · DOI
  30. Milstien S, Gude D, Spiegel S (2007) Sphingosine 1-phosphate in neural signalling and function. Acta Paediatr 96:40 -43. CrossRef Medline · DOI
  31. Neumann H (2001) Control of glial immune function by neurons. Glia 36: 191-199. CrossRef Medline · DOI · Paper page
  32. Okada T, Kajimoto T, Jahangeer S, Nakamura S (2009) Sphingosine kinase/ sphingosine 1-phosphate signalling in central nervous system. Cell Signal 21:7-13. CrossRef Medline · DOI
  33. Pocock JM, Kettenmann H (2007) Neurotransmitter receptors on micro- glia. Trends Neurosci 30:527-535. CrossRef Medline · DOI · Paper page
  34. Pyne NJ, Pyne S (2011) Selectivity and specificity of sphingosine 1-phosphate receptor ligands: "off-targets" or complex pharmacology? Frontiers Pharmacol 2:26. CrossRef Medline · DOI
  35. Rosenmund C, Stevens CF (1996) Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16:1197-1207. CrossRef Medline · DOI
  36. Schenk U, Menna E, Kim T, Passafaro M, Chang S, De Camilli P, Matteoli M (2005) A novel pathway for presynaptic mitogen-activated kinase activa- tion via AMPA receptors. J Neurosci 25:1654 -1663. CrossRef Medline · DOI
  37. Schlegelmilch T, Henke K, Peri F (2011) Microglia in the developing brain: from immunity to behaviour. Curr Opin Neurobiol 21:5-10. CrossRef Medline · DOI
  38. Strelow A, Bernardo K, Adam-Klages S, Linke T, Sandhoff K, Kro ¨nke M, Adam D (2000) Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death. J Exp Med 192:601-612. CrossRef Medline · DOI
  39. Toman RE, Payne SG, Watterson KR, Maceyka M, Lee NH, Milstien S, Bigbee JW, Spiegel S (2004) Differential transactivation of sphingosine-1- phosphate receptors modulates NGF-induced neurite extension. J Cell Biol 166:381-392. CrossRef Medline · DOI
  40. Turola E, Furlan R, Bianco F, Matteoli M, Verderio C (2012) Microglial microvesicle secretion and intercellular signaling. Front Physiol 3:149. CrossRef Medline · DOI
  41. Valentine WJ, Kiss GN, Liu J, Gotoh M, Murakami-Murofushi K, Pham TC, Baker DL, Parrill AL, Lu X, Sun C, Bittman R, Pyne NJ, Tigyi G (2010) (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity. Cell Signal 22:1543-1553. CrossRef Medline · DOI
  42. Verderio C, Coco S, Fumagalli G, Matteoli M (1994) Spatial changes in calcium signaling during the establishment of neuronal polarity and syn- aptogenesis. J Cell Biol 126:1527-1536. CrossRef Medline · DOI
  43. Verderio C, Pozzi D, Pravettoni E, Inverardi F, Schenk U, Coco S, Proux- Gillardeaux V, Galli T, Rossetto O, Frassoni C, Matteoli M (2004) SNAP-25 modulation of calcium dynamics underlies differences in GABAergic and glutamatergic responsiveness to depolarization. Neuron 41:599 -610. CrossRef Medline · DOI
  44. Verderio C, Muzio L, Turola E, Bergami A, Novellino L, Ruffini F, Riganti L, Corradini I, Francolini M, Garzetti L, Maiorino C, Servida F, Vercelli A, Rocca M, Dalla Libera D, Martinelli V, Comi G, Martino G, Matteoli M, Furlan R (2012) Myeloid microvesicles are a marker and therapeutic target for neuroinflammation. Ann Neurol 72:610 -624. CrossRef Medline · DOI · Paper page

Cited by

Sorted by citations

Authors
Riganti, L., Antonucci, F., Gabrielli, M., Prada, I., Giussani, P., Viani, P., Valtorta, F., Menna, E., Matteoli, M., & Verderio, C.
Venue
The Journal of Neuroscience
Published
2016-04-20
Volume
36
Issue
16
Pages
4624-4634
ISSN
  • 0270-6474
  • 1529-2401
Cited by
65
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review